ST天玑 reported revenue of ¥0.13B for the period ended 2026-06-30, -15.1% year on year. Net income was ¥-0.05B, a -38.0% net margin on a 12.0% gross margin. The largest revenue line is IT支持与维护 at 44% of the total. Free cash flow for the period was ¥-0.00B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.13B | -15.1% |
| Gross profit | ¥0.01B | — |
| Operating income | ¥-0.05B | — |
| Net income | ¥-0.05B | — |
| Gross margin | 12.0% | Net margin -38.0% |
| Revenue Q/Q | -2.5% | — |
| Segment | Revenue | Share |
|---|---|---|
| IT支持与维护 | ¥0.05B | 43.7% |
| IT外包服务 | ¥0.04B | 30.9% |
| 其他 | ¥0.02B | 12.4% |
| IT专业服务 | ¥0.01B | 10.3% |
| 其他(补充) | ¥0.00B | 1.7% |
| 其他主营业务 | ¥0.00B | 1.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.11B | 88.0% |
| R&D | ¥0.02B | 15.3% |
| SG&A | ¥0.06B | 44.3% |
| Tax & other | ¥0.00B | 0.8% |
| Item | Amount |
|---|---|
| Total assets | ¥1.38B |
| Total liabilities | ¥0.25B |
| Shareholders' equity | ¥1.13B |
| Equity / assets | 81.6% |
| Operating cash flow | ¥0.01B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.00B |
| Cash conversion (OCF / net income) | -56% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
宝莱特 ・ 融捷健康 ・ 新开普 ・ 依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies